XML 23 R7.htm IDEA: XBRL DOCUMENT v3.10.0.1
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
3 Months Ended
Jul. 31, 2018
Jul. 31, 2017
Cash flows from operating activities:    
Net (loss) income $ (38,592) $ 29,429
Adjustments to reconcile net (loss) income to net cash used in operating activities:    
Depreciation and amortization 11,731 12,209
Stock-based compensation expense 5,714 4,696
Tradename write-offs 106,555  
Provision for doubtful accounts 3,707 3,070
Gain on cash surrender value of life insurance policies (1,347) (2,485)
Gain on marketable securities (4,001) (3,429)
Deferred income taxes (22,564) 8,562
Change in other assets and liabilities:    
Deferred compensation 3,021 8,288
Receivables due from clients (16,270) (23,413)
Income taxes and other receivables (7,811) (10,930)
Prepaid expenses and other assets (4,356) (4,780)
Unearned compensation (17,463) (29,115)
Investment in unconsolidated subsidiaries (29) (30)
Income taxes payable 1,434 6,463
Accounts payable and accrued liabilities (135,405) (109,034)
Other (1,816) 926
Net cash used in operating activities (117,492) (109,573)
Cash flows from investing activities:    
Purchase of property and equipment (13,163) (9,529)
Purchase of marketable securities (1,396) (4,600)
Proceeds from sales/maturities of marketable securities 8,240 1,734
Premium on company-owned life insurance policies (398) (403)
Proceeds from life insurance policies 85 971
Dividends received from unconsolidated subsidiaries   60
Net cash used in investing activities (6,632) (11,767)
Cash flows from financing activities:    
Principal payments on term loan facility (5,156) (5,156)
Payment of contingent consideration from acquisitions (455) (485)
Repurchases of common stock   (4,026)
Payments of tax withholdings on restricted stock (13,054) (3,346)
Proceeds from issuance of common stock upon exercise of employee stock options and in connection with an employee stock purchase plan 4,105 3,984
Dividends paid to shareholders (6,027) (5,823)
Payments on life insurance policy loans   (414)
Net cash used in financing activities (20,587) (15,266)
Effect of exchange rate changes on cash and cash equivalents (10,408) 7,743
Net decrease in cash and cash equivalents (155,119) (128,863)
Cash and cash equivalents at beginning of period 520,848 410,882
Cash and cash equivalents at end of the period $ 365,729 $ 282,019